Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Nan Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0679-6188; OpenAlex author ID A5100331321. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Charlson syndrome index predicted survival in pancreatic cancer patients received immunotherapy. Co-author DOI 10.3389/fimmu.2025.1487318↗
  2. A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram. Co-author DOI 10.1016/j.canlet.2017.08.028↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ru Jia · 1 shared paper, 2025 · strength 0.30
  2. Shiyun Chen · 1 shared paper, 2025 · strength 0.30
  3. Guanghai Dai · 1 shared paper, 2025 · strength 0.30
  4. Theodore Sunki Hong · 1 shared paper, 2017 · strength 0.05
  5. Juan Cong · 1 shared paper, 2017 · strength 0.05
  6. Lei Cai · 1 shared paper, 2017 · strength 0.05
  7. Theodoros P. Michelakos · 1 shared paper, 2017 · strength 0.05
  8. Kenneth K. Tanabe · 1 shared paper, 2017 · strength 0.05
  9. Soldano Ferrone · 1 shared paper, 2017 · strength 0.05
  10. Xinhui Wang · 1 shared paper, 2017 · strength 0.05
  11. Yangyang Wang · 1 shared paper, 2017 · strength 0.05
  12. Cristina Rosa Ferrone · 1 shared paper, 2017 · strength 0.05
  13. Keith D. Lillemoe · 1 shared paper, 2017 · strength 0.05
  14. Bryan C. Fuchs · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.